Xeljanz 00069-1029
Generic: Tofacitinib
Product NDC
00069-1029- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Dosage Form
- Solution
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- February 8, 2021
- Listing Expires
- December 31, 2027
- Application
- NDA213082
Need to source Xeljanz? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tofacitinib Citrate | 1 mg/mL |
Drug Class
Janus Kinase Inhibitor [EPC]Janus Kinase Inhibitors [MoA]
Packaging Options(1)
1 BOTTLE in 1 CARTON (0069-1029-02) / 240 mL in 1 BOTTLE (0069-1029-01)